Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
HTML
PDF
Details
Locations
Year:
2017
Type:
article
Source:
New England Journal of Medicine
DOI:
10.1056/nejmx170012
Language:
English
Topic:
PARP inhibition in cancer therapy
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
olaparib,
metastatic breast cancer,
germline BRCA mutation,
PARP inhibitors,
targeted therapy,
BRCA1,
BRCA2
show all 7
SDG:
Good health and well-being
Open Access status:
bronze
OpenAlex ID:
W4250901122
FWCI:
21.07
Cites:
Cited by:
439
Related to:
10